U.S. Open Preview and Significant News Developments: Immigration Confusion, Investigations, and Health Advocacy
U.S. Open Championship Preview and Other Key News Updates As the U.S. Open tennis tournament approaches this weekend, world-renowned athletes Aryna Sabalenka and Jannik Sinner are set to defend their titles. Both players currently hold the top rank in global tennis, creating high expectations for their performances. In a recent episode of “The Daily Report,” […]
U.S. Open Preview and Significant News Developments: Immigration Confusion, Investigations, and Health Advocacy
U.S. Open Championship Preview and Other Key News Updates As the U.S. Open tennis tournament approaches this weekend, world-renowned athletes Aryna Sabalenka and Jannik Sinner are set to defend their titles. Both players currently hold the top rank in global tennis, creating high expectations for their performances. In a recent episode of “The Daily Report,” […]
[Comment] Ecnoglutide, a biased GLP-1 receptor agonist as a potential new player for type 2 diabetes management?
GLP-1 receptor agonists have been used to treat type 2 diabetes since 2005 and gained approval for weight management in 2014.1 However, a high between-individual heterogeneity should be acknowledged regarding the glucose-lowering potency and weight reduction efficacy. Furthermore, GLP-1 receptor agonists are associated with side-effects, especially gastrointestinal disturbances, leading some patients to prematurely abandon treatment. […]
[Articles] Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
Once-weekly ecnoglutide 0·6 mg and 1·2 mg were non-inferior to dulaglutide 1·5 mg in reducing HbA1c in adults with type 2 diabetes and elevated glucose concentrations on metformin monotherapy. Although the 1·2 mg dose showed statistically significantly greater reductions in HbA1c from baseline to week 32 than dulaglutide 1·5 mg, the difference was not considered […]
New jab that’s ‘cheaper than Ozempic and Mounjaro’ melts fat at double the rate of other GLP-1 drugs
A NEW drug developed to combat diabetes and obesity melts fat at double the rate of other GLP-1 drugs, scientists say. The injection is also quicker and cheaper to produce than currently available medications like Ozempic or Mounjaro. PAPatients taking ecnoglutide lost more weight than those on dulaglutide[/caption] Ecnoglutide is a new GLP-1 receptor agonist […]
What to know about pregnancy and GLP-1s as Serena Williams makes headlines
Serena Williams made headlines this week, not for her tennis court achievements, but for her health challenges since giving birth to her two children. She revealed she lost about 30 pounds by using a GLP-1 medication, such as Wegovy and Zepbound, through the telehealth company Ro. She serves as a paid spokesperson. CBS News’ Dr. […]
What to know about pregnancy and GLP-1s as Serena Williams makes headlines
Serena Williams made headlines this week, not for her tennis court achievements, but for her health challenges since giving birth to her two children. She revealed she lost about 30 pounds by using a GLP-1 medication, such as Wegovy and Zepbound, through the telehealth company Ro. She serves as a paid spokesperson. CBS News’ Dr. […]
Serena Williams speaks out about the stigma of using GLP-1s for weight loss and the pressure to bounce back after babies
The US Open starts on Sunday, and tennis GOAT Serena Williams is making headlines, but not for her sport. She told PEOPLE magazine that she used a GLP-1 drug to lose 31 pounds, and she is teaming up with telehealth company Ro to promote the weight loss drugs. I’ve said before I don’t really care […]
FDA OKs First-Ever Glucose Monitoring System for Weight Loss: What to Know
The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring system specifically designed for weight management, from startup Signos, providing a new option for maintaining a healthy weight. The system uses a continuous glucose monitor, or CGM, […]
This common mistake can mess with your body’s natural Ozempic hormones — and up your odds of getting diabetes
Medications like Ozempic mimic the GLP-1 hormone, so the user feels fuller for longer and doesn’t crave food as often.